Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PREMISCORP-Premium is an equine-derived polyclonal antiserum developed by Premium Serums and Vaccines for the treatment of scorpion envenomation, specifically targeting Indian scorpions such as the red scorpion (*Buthus tamulus*). The drug consists of enzyme-refined equine immunoglobulins that function by binding to and neutralizing the various toxins present in scorpion venom, thereby preventing their systemic effects. It is supplied as a lyophilized powder that requires reconstitution with sterile water for injection prior to administration. PREMISCORP-Premium is an approved therapeutic biologic used in clinical settings to manage life-threatening scorpion stings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PREMISCORP-Premium.